The Relationship Between Body Mass Index and In-Hospital Mortality in Bacteremic Sepsis
Overview
Authors
Affiliations
Background: The association between Body Mass Index (BMI) and clinical outcomes following sepsis continues to be debated. We aimed to investigate the relationship between BMI and in-hospital clinical course and mortality in patients hospitalized with bacteremic sepsis using real-world data.
Methods: A sampled cohort of patients hospitalized with bacteremic sepsis between October 2015 and December 2016 was identified in the National Inpatient Sample (NIS) database. In-hospital mortality and length of stay were defined as the relevant outcomes. Patients were divided into 6 BMI (kg/m) subgroups; (1) underweight ≤ 19, (2) normal-weight 20-25, (3) over-weight 26-30, (4) obese I 31-35, (5) obese II 36-39, and (6) obese stage III ≥ 40. A multivariable logistic regression model was used to find predictors of mortality, and a linear regression model was used to find predictors of an extended length of stay (LOS).
Results: An estimated total of 90,760 hospitalizations for bacteremic sepsis across the U.S. were analyzed. The data showed a reverse-J-shaped relationship between BMI and study population outcomes, with the underweight patients (BMI ≤ 19 kg/m) suffering from higher mortality and longer LOS as did the normal-weight patients (BMI 20-25 kg/m) when compared to the higher BMI groups. The seemingly protective effect of a higher BMI diminished in the highest BMI group (BMI ≥ 40 kg/m). In the multivariable regression model, BMI subgroups of ≤19 kg/m and ≥40 kg/m were found to be independent predictors of mortality.
Conclusions: A reverse-J-shaped relationship between BMI and mortality was documented, confirming the "obesity paradox" in the real-world setting in patients hospitalized for sepsis and bacteremia.
Impact of underweight status on mortality in sepsis patients: a meta-analysis.
Chen J, Zhang F, Liang L, Pan X, Zhang J, Jin G Front Med (Lausanne). 2025; 12:1549709.
PMID: 39981083 PMC: 11839434. DOI: 10.3389/fmed.2025.1549709.
Cui K, Teng X, Liu W, Zhao X, Xu S, Bai L Diabetol Metab Syndr. 2025; 17(1):43.
PMID: 39901292 PMC: 11789304. DOI: 10.1186/s13098-025-01607-w.
Lin W, Lin B, Chen J, Li R, Yu Y, Huang S Sci Rep. 2024; 14(1):31535.
PMID: 39733192 PMC: 11682055. DOI: 10.1038/s41598-024-83260-3.
Xu H, Liu Y, Niu H, Wang H, Zhan F PLoS One. 2024; 19(8):e0308471.
PMID: 39106284 PMC: 11302852. DOI: 10.1371/journal.pone.0308471.
Yao S, Yagi S, Sugimoto T, Asahara T, Uemoto S, Hatano E Surg Today. 2023; 54(6):596-605.
PMID: 38072872 DOI: 10.1007/s00595-023-02778-7.